Brazil Says It’s Ready and Willing to Break AIDS Drugs Patents

    According to Pedro Chequer, the coordinator of Brazil’s Sexually Transmitted Disease/Aids program, the country may break patents with pharmaceutical companies and manufacture generic versions of up to a total of five brand name retroviral drugs.

    “There is a concrete possibility that we will break patents under existing international agreements. And we now have the technical capacity to begin manufacturing next year. We will be able to deal with the manufacturing process all the way from the molecular level to the finished product,” he said.


    However, Chequer refused to specifiy which AIDS drugs, out of the eight Brazil presently has to import, could have their patents broken.


    He also did not disclose the amount of money Brazil was spending on research, but he did say that the Brazilian Development Bank (BNDES), along with laboratories in both the public and private sectors, were running studies on the country’s capabilities with the objective of eventually creating a new reality with new perspectives in the pharmaceutical area.


    “What this means is that besides the seven AIDS drugs we already make generic versions of, we will expand our production capacity significantly with another three to five generic versions of other brand name drugs,” said Chequer.


    The justification for breaking patents, explained Chequer, is that Brazil is forced to spend too much on imported AIDS drugs which could be made domestically in public or private labs.


    He points out that around 80% of his budget (some US$ 165 million or R$ 450 million) goes to paying for the importation of only seven drugs that are used in treating AIDS.


    Brazil’s Sexually Transmitted Disease/AIDS program, as part of the Brazilian public health network (SUS), supplies approximately 150,000 HIV-positive patients with 15 drugs free of charge to treat the disease and keep it under control.


    Out of those 15 drugs, seven are now produced in Brazil in generic versions and the remaining eight are imported. Among the eight imported drugs is the newest in the so-called AIDS cocktail, Aazanavir, which is made in the United States by Bristol-Myers Squibb.


    Agência Brasil
    Translator: Allen Bennett

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    December 1993

    CONTENTS: Cover: Overhauling the Constitution (p. 7) Literature: Lygia Fagundes Telles’s short story (p. ...

    Franklin Martins at the time he was wanted by the police

    Brazil’s New Cabinet Has Man Who Kidnapped US Ambassador in 1969

    Brazilian President Lula da Silva and his newly formed ruling coalition completed the reshuffling ...

    Factory in Diadema, São Paulo, Brazil

    Several Indexes Show Brazil’s Industry Confidence Dropping

    Brazil's Industrial Confidence Index (ICI), as measured by the Getúlio Vargas Foundation (FGV), had ...

    Amateur Lover

    He always used to bring a rose stolen from his mother’s vase, from the ...

    Fall of Brazil’s Chief of Staff Is Black Day for Lula

    {mosimage}The South African President, Thabo Mbeki, sacked his deputy Jacob Zuma on 14 June ...

    New Data on Brazil’s Low Competitiveness Are Not Accurate, Says Minister

    Brazil dropped eight places in the global competitiveness ranking, according to a report released ...

    DM factory in Diadema, Brazil

    Brazil Industry Has Worst Semester Since 1975

    In Brazil, the industry grew 0.2% in June when compared to May, the sixth ...

    Again, World Oil Prices Put a Damp on Brazilian Markets

    Brazilian and Latin American stocks dipped, Friday, January 20, as investors fretted over the ...

    Commodity Stocks Push Brazil Down

    Brazilian and most Latin American markets closed lower, as ongoing selling in commodity-related stocks ...